Don’t send me to Mumbai; I will be killed there: Ravi Poojary to cops

Mangaluru, Jun 3: A banner that read "Veer Savarkar Flyover Pumpwell" surfaced on the sidewall of the Pumpwell flyover in Mangaluru on Tuesday night.

It is suspected that activists of Bajrang Dal put up the controversial banner. Though it was removed later, it sparked debates on social media and photos of it went viral.

The development comes amid the controversy over the naming of a flyover at Yelahanka in Bengaluru after Savarkar.

A Hindutva ideologue, Savarkar has tendered apology to British imperialists and pledged to support them following his arrest during India’s freedom movement.

Bengaluru, May 19: Karnataka on Tuesday recorded the highest single-day rise in the COVID-19 cases in the state as a whooping 149 people tested positive for the virus. With the spike in new cases, the overall tally has risen to 1,395.

This is for the first time the state recorded 100 plus cases in a single day. So far, 40 people have also succumbed to the virus including three deaths today. 

The new deaths consist of a 61-year-old male patient, a resident of Ballari; a 65-year-old male patient, a resident of Vijayapura; and a 54-year-old male patient from Bengaluru.

Among the new cases, a maximum of 71 are reported from Mandya, followed by 22 in Davanagere, 10 in Shivamogga, 13 in Kalaburgi, six in Bengaluru Urban, four each in Udupi and Uttara Kannada, five in Chikkamagaluru, three in Hassan and one each in Yadagiri, Chitradurga, Vijayapura, Gadag.

Most of the new cases are of the people who traveled to Mumbai in Maharashtra, Solapur, Ahmedabad, and Kerala.

The remaining are those who came in contact with the people who had tested positive earlier.

At present, 811 people are actively taking treatment, while 543 have been discharged after recovery.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.